The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 7 May 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 339K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peschel, A.
Right arrow Articles by van Strijp, J. A.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peschel, A.
Right arrow Articles by van Strijp, J. A.G.
Right arrowPubmed/NCBI databases
*Domain*Gene
*Protein
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics
Hazardous Substances DB
*L-LYSINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/5/1067/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 9, May 7, 2001 1067-1076


Original Article

Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with L-Lysine

Andreas Peschela,b, Ralph W. Jackc,d, Michael Ottoa, L. Vincent Collinse, Petra Staubitza, Graeme Nicholsonc, Hubert Kalbacherf, Willem F. Nieuwenhuizeng, Günther Jungc,d, Andrej Tarkowskie, Kok P.M. van Kesselb, and Jos A.G. van Strijpb

a Microbial Genetics, University of Tuebingen, 72076 Tuebingen, Germany
b Eijkman Winkler Institute, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
c Organic Chemistry, University of Tuebingen, 72076 Tuebingen, Germany
d EMC Microcollections®, 72070 Tuebingen, Germany
e Department of Rheumatology, University of Goeteborg, S-41346 Goeteborg, Sweden
f Medical and Natural Sciences Research Center, University of Tuebingen, 72074 Tuebingen, Germany
g TNO Nutrition and Food Research, 3700 AJ Zeist, The Netherlands
Microbial Genetics, University of Tuebingen, Auf der Morgenstelle 28E, 72076 Tuebingen, Germany.49-7071-29-506549-7071-297-2611

andreas.peschel{at}uni-tuebingen.de

Defensins, antimicrobial peptides of the innate immune system, protect human mucosal epithelia and skin against microbial infections and are produced in large amounts by neutrophils. The bacterial pathogen Staphylococcus aureus is insensitive to defensins by virtue of an unknown resistance mechanism. We describe a novel staphylococcal gene, mprF, which determines resistance to several host defense peptides such as defensins and protegrins. An mprF mutant strain was killed considerably faster by human neutrophils and exhibited attenuated virulence in mice, indicating a key role for defensin resistance in the pathogenicity of S. aureus. Analysis of membrane lipids demonstrated that the mprF mutant no longer modifies phosphatidylglycerol with L-lysine. As this unusual modification leads to a reduced negative charge of the membrane surface, MprF-mediated peptide resistance is most likely based on repulsion of the cationic peptides. Accordingly, inactivation of mprF led to increased binding of antimicrobial peptides by the bacteria. MprF has no similarity with genes of known function, but related genes were identified in the genomes of several pathogens including Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Enterococcus faecalis. MprF thus constitutes a novel virulence factor, which may be of general relevance for bacterial pathogens and represents a new target for attacking multidrug resistant bacteria.

Key Words: host defense peptides • oxygen-independent killing • Staphylococcus aureus virulence • phospholipids • innate immunity


Abbreviations used in this paper: DPG, diphosphatidylglycerol; FT-ICR, Fourier transform ion cyclotron resonance; GC, gas chromatography; HNP, human neutrophil peptide; HSA, human serum albumin; L-PG, lysylphosphatidylglycerol; MIC, minimal inhibitory concentration; MPO, myeloperoxidase; MS, mass spectrometry; PG, phosphatidylglycerol; RP-HPLC, reversed phase HPLC; 2d-TLC, two-dimensional TLC.

R.W. Jack's present address is Department of Biology and Chemistry, City University of Hong Kong, 83 Tat Chee Ave., Kowloon Tong, Kowloon, Hong Kong.

M. Otto's present address is Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th St., Hamilton, MT 59840.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS